ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Act To Get Only One-Year Extension Now NCAB; ACCC, ACI Adopt Recommendations For changes

February 4, 1977